Search | IOVS | ARVO Journals

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs)

Dante Joseph Pieramici; Frank Holz; Jeffrey S. Heier; Srinivas R. Sadda; Brandon G Busbee; Emily Y. Chew; Paul Mitchell; Adnan Tufail; Christopher Brittain; Daniela Ferrara; Sarah Gray; Lee Honigberg; Jillian Martin; Barbara Tong; Jason Ehrlich; Neil M Bressler

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4948. doi:

ARVO Annual Meeting Abstract March 2012

Visual Acuity and Injection Frequency Results of 2mg Ranibizumab for Pigment Epithelial Detachments Refractory to Conventional Dosing in the HiPED study

Anne E. Fung; Brandon G. Busbee; John W. Kitchens; Jan Kristine Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4180. doi:

ARVO Annual Meeting Abstract March 2012

Volumetric SDOCT Imaging of Pigment Epithelial Detachments in the HiPED Study

Jan Kristine T. Bayabo; Anne E. Fung; John W. Kitchens; Brandon G. Busbee; Brandon J. Lujan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):818. doi:

ARVO Annual Meeting Abstract March 2012

Fluorescein Angiographic Response to 2mg Ranibizumab for AMD Pigment Epithelial Detachments Refractory to Conventional Dosing in the HiPED Study

Edward H. Wood; John W. Kitchens; Anne E. Fung; Brandon G. Busbee; Jan K. Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2040. doi:

ARVO Annual Meeting Abstract March 2012

OCT response to 2mg ranibizumab for AMD Pigment Epithelial Detachments refractory to conventional dosing in the HiPED study

Brandon G. Busbee; Anne E. Fung; John W. Kitchens; Brandon J. Lujan; Jan Kristine Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2041. doi:

ARVO Annual Meeting Abstract April 2011

Ranibizumab Pharmacokinetics in Retinal Vein Occlusion

Brandon G. Busbee; Wendy Yee Murahashi; Zhenling Yao; Yi Zhang

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4874. doi:

Advertisement